TECARTUS
NDC 71287-219 · Kite Pharma, Inc.
Generic namebrexucabtagene autoleucel
Dosage formSUSPENSION
RouteINTRAVENOUS
Active ingredient(s)BREXUCABTAGENE AUTOLEUCEL
Strength2000000 1/68mL
Marketing categoryBLA
Packages
71287-219-02 — 1 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-219-01)
Billed under HCPCS
Q2053 — Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Medicare Part B payment limit (ASP + 6%): $510103.92
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
71287-220 — brexucabtagene autoleucel